Showing results (1-10 of 350) with videos related to
Sort By:
Pageof 35
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Next-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advancesDung T Le, Elizabeth M JaffeeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Harnessing immune responses in the tumor microenvironment: all signals neededDung T Le, Elizabeth M JaffeeCancer Research|July 5, 2012
Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspectiveDung T Le, Elizabeth M JaffeeCancer Journal (Sudbury, Mass.)|August 10, 2010
Cellular vaccine approachesDung T Le, Drew M Pardoll, Elizabeth M JaffeeJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?Raffit Hassan, Anish Thomas, Christine Alewine, et al.Cancer Discovery|April 17, 2023
Converging on a Cure: The Roads to Predictive ImmunotherapyGenevieve L Stein-O'Brien, Dung T Le, Elizabeth M Jaffee, et al.International Journal of Cancer|September 22, 2010
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor responseDung T Le, Brian H Ladle, Timothy Lee, et al.Cancer Immunology Research|March 6, 2020
Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic CancerNitya Nair, Shih-Yu Chen, Ed Lemmens, et al.Frontiers in Oncology|June 23, 2023
Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p.V600E mutation and mismatch repair deficiencyEric S Christenson, Hua-Ling Tsai, Dung T Le, et al.Nature Reviews. Cancer|May 21, 2005
Immunotherapy for pancreatic cancer - science driving clinical progressDan Laheru, Elizabeth M JaffeePageof 35